Skip to content

Drug interactions

Atorvastatin + Nintedanib

Severity: Minor

Atorvastatin and Nintedanib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nintedanib is a P-glycoprotein substrate, and atorvastatin is a weak P-gp inhibitor, so nintedanib exposure may rise slightly. The effect is unlikely to be clinically significant.

What this interaction means in plain words

Atorvastatin and Nintedanib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Atorvastatin belongs to Cardiovascular; Nintedanib belongs to Oncology.

Evidence level: Low

Why it happens

Weak P-glycoprotein inhibition by atorvastatin may reduce nintedanib efflux.

What to do

No dose change is usually needed. Monitor for gastrointestinal effects and liver enzyme elevation, which are typical of nintedanib.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atorvastatin and Nintedanib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Atorvastatin with Nintedanib?

MediHelp rates the interaction as minor. Atorvastatin and Nintedanib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Nintedanib is a P-glycoprotein substrate, and atorvastatin is a weak P-gp inhibitor, so nintedanib exposure may rise slightly. The effect is unlikely to be clinically significant.

How serious is the interaction between Atorvastatin and Nintedanib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually needed. Monitor for gastrointestinal effects and liver enzyme elevation, which are typical of nintedanib.

What other medicines interact with Atorvastatin?

MediHelp also lists interactions of Atorvastatin with, for example, Tipranavir, Atazanavir, Clarithromycin. The full list is on the Atorvastatin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in